טוען...
Properties of resistant cells generated from lung cancer cell lines treated with EGFR inhibitors
BACKGROUND: Epidermal growth factor receptor (EGFR) signaling plays an important role in non-small cell lung cancer (NSCLC) and therapeutics targeted against EGFR have been effective in treating a subset of patients bearing somatic EFGR mutations. However, the cancer eventually progresses during tre...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3364915/ https://ncbi.nlm.nih.gov/pubmed/22433462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-95 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|